1020023290p.pdf

PDF 329 KB Posted

Attached to
MMCAP Infuse Influenza Vaccines (Statewide)
Contract number
PGB-23290
Issued by
New York

About this file

This document is a series of Contract Award Notification Updates from the New York State Office of General Services (NYS OGS) for a statewide influenza vaccine contract. The contract involves Sanofi Pasteur Inc. as the contractor and is a piggyback contract based on the MMCAP Infuse Master Contract MMS52200727. The contract covers the period from March 27, 2023, to December 31, 2025, with multiple updates regarding contract management, reservation policies, and contract extension.

The contract pertains to the procurement of influenza vaccines for the 2023-2024 and 2024-2025 seasons. Key updates include an extension of the contract period, changes to cancellation and return policies, and modifications to prebook reservation procedures. Specifically, members can return up to fifteen percent of each vaccine presentation for full credit, and reservations can be placed with certain restrictions on modifications after confirmation. The contract provides flexibility for members to place orders, with shipping commitments based on confirmed reservations, and includes provisions for order modifications and cancellations prior to shipment.

View the file

Other files

File Type Posted
1020023290TC_Sanofi.pdf PDF
1020023290PL_Sanofi.pdf PDF
1020023290ra.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

23290p03

Corning Tower, Empire State Plaza, Albany, NY 12242 | https://ogs.ny.gov/procurement | customer.services@ogs.ny.gov | 518-474-6717

Contract Award Notification Update Subject: Contract Extension & Updates to Contractor

Information and OGS Contract Manager DATE: October 22, 2024 AWARD #: PGB-23290 GROUP #: 10200

AWARD DESCRIPTION: MMCAP Infuse Influenza Vaccines (Statewide)

CONTRACT PERIOD: March 27, 2023 – December 31, 2025

CONTACT: Sara Welsh | 518-473-8102 | sara.welsh@ogs.ny.gov

CONTRACT NO.: PC69850 CONTRACTOR: Sanofi Pasteur Inc.

The Influenza Vaccines Contract with Sanofi Pasteur Inc. has been extended from December 31, 2024, to December 31, 2025.

This extension is based upon the MMCAP Infuse Master Agreement with Sanofi Pasteur Inc. and its approval to extend their Agreement through December 31, 2025, via Amendment No. 5 to MMS2200727.

The new expiration is coterminous with the Master Agreement per Section 2.2 of the subject NYS centralized piggyback contract.

The Contractor has updated their contact information as follows:

Amanda Medrano Phone: 570-580-7875 E-mail: Amanda.medrano@sanofi.com

The OGS Contract Manager for this Award has changed from Julie Carlson to Sara Welsh.

Contact Information:

Sara Welsh, CMS1 Phone: 518-473-8102 Email: sara.welsh@ogs.ny.gov

More information about this award can be found at the following link:

https://ogs.ny.gov/award-23290

Should you have any questions concerning this Contract Award Notification Update, please contact the contract manager using the above listed contact information.

https://ogs.ny.gov/award-23290

23290p02

Corning Tower, Empire State Plaza, Albany, NY 12242 | https://ogs.ny.gov/procurement | customer.services@ogs.ny.gov | 518-474-6717

Subject: Contract Manager Update DATE: September 28, 2023 AWARD #: PGB-23290 GROUP #: 10200

AWARD DESCRIPTION: MMCAP Infuse Influenza Vaccines (Statewide)

CONTRACT PERIOD: March 27, 2023– December 31, 2024

CONTACT: Julie Carlson | 518-474-8077 | Julie.Carlson@ogs.ny.gov

CONTRACT NO.: PC69850 CONTRACTOR: Sanofi Pasteur Inc.

The NYS OGS Contract Management Specialist contact for this award has changed.

New Contract Manager information is:

Name: Julie Carlson Title: Contract Management Specialist Phone: 518-474-8077 Email: Julie.Carlson@ogs.ny.gov

All other terms and conditions of the Award remain unchanged.

https://online.ogs.ny.gov/purchase/spg/awards/1020023290CAN.HTM

23290p01

Corning Tower, Empire State Plaza, Albany, NY 12242 | https://ogs.ny.gov/procurement | customer.services@ogs.ny.gov | 518-474-6717

Subject: Prebook Reservation Deadline Extension and

Cancellation and Return Policy Update DATE: April 12, 2023 AWARD #: PGB-23290 GROUP #: 10200 AWARD DESCRIPTION: MMCAP Infuse Influenza Vaccines (Statewide) CONTRACT PERIOD: March 27, 2023– December 31, 2024

CONTACT: Vivian Basile | 518-474-0912 | vivian.basile@ogs.ny.gov

CONTRACT NO.: PC69850 CONTRACTOR: Sanof i Pasteur Inc.

Please note that the above referenced contract is a Piggyback Contract off MMCAP Infuse Master Contract MMS52200727. MMCAP Infuse updated the following provisions in its Master Contract MMS52200727 via Amendment No. 2 and Amendment No. 3:

1. MMCAP Infuse Master Contract Paragraph 3.6(C) is revised via Amendment No. 2 to MMS2200727 as follows:

C. Cancellation and Changes: Members may modify or cancel any pre-booked orders any time prior to shipment. After the reservation period, Members cannot cancel/reduce their confirmed reservation. Vendor will send an email confirmation to each Member once their order(s) have been processed and respective prebook doses are available.

2. MMCAP Infuse Master Contract Paragraph 1 of Attachment A, 2023-2024 Pricing and Shipping

Commitments is revised via Amendment No. 2 and 3 to MMS2200727 as follows:

1) Reservations may be placed until March 31, 2023 April 14, 2023. Shipping commitment timelines and percentages of total confirmed influenza vaccine reservation will be based only on conf irmed reservations as of March 31, 2023 April 14, 2023. After March 31, 2023, reservation requests will be accepted subject to product availability the reservation period, Members cannot cancel or reduce their confirmed reservation.

3. MMCAP Infuse Master Contract Paragraph 5(a) of Attachment A, 2023-2024 Pricing and Shipping

Commitments is revised via Amendment No. 2 to MMS2200727 as follows:

5) Returnability: For direct purchases from Sanofi Pasteur Inc. for the current influenza season, Members may return a limited number of unused and expired doses for credit toward future purchases of influenza vaccines as follows:

a. Ten (10) Fifteen (15) percent of each presentation of each customer’s influenza vaccine shipped during the 2023-2024 influenza season may be returned for full credit.

All other terms and conditions of the Award remain unchanged.

https://online.ogs.ny.gov/purchase/spg/awards/1020023290CAN.HTM

File details come from the government source that posted it. Updated .